DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

CymaBay Therapeutics Q4 EPS $(0.43) Misses $(0.39) Estimate

CymaBay Therapeutics (NASDAQ:CBAY) reported quarterly losses of $(0.43) per share which missed the analyst consensus estimate of $(0.39) by 10.26 percent. This is a 34.37 percent decrease over losses of $(0.32) per share

Benzinga · 03/12/2020 20:01

CymaBay Therapeutics (NASDAQ:CBAY) reported quarterly losses of $(0.43) per share which missed the analyst consensus estimate of $(0.39) by 10.26 percent. This is a 34.37 percent decrease over losses of $(0.32) per share from the same period last year.